Literature DB >> 7695833

Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.

Y Takakura1, M Hashida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7695833     DOI： 10.1016/1040-8428(94)00131-c

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  12 in total

1.  Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.

Authors:  U Beyer; B Rothern-Rutishauser; C Unger; H Wunderli-Allenspach; F Kratz
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.

Authors:  H Hirabayashi; M Nishikawa; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

Review 3.  Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.

Authors:  Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

4.  Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors.

Authors:  T Nomura; N Koreeda; F Yamashita; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

5.  Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system.

Authors:  A Saikawa; T Nomura; F Yamashita; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

6.  Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.

Authors:  B J Bowman; C M Ofner
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

Review 7.  Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.

Authors:  Chayan Acharya; Andrew Coop; James E Polli; Alexander D Mackerell
Journal:  Curr Comput Aided Drug Des       Date:  2011-03       Impact factor: 1.606

8.  The effect of molecular weight, drug load, and charge of gelatin-MTX conjugates on growth inhibition of HL-60 leukemia cells.

Authors:  Chao-Sheng Chen; Clyde M Ofner
Journal:  Pharm Res       Date:  2008-10-31       Impact factor: 4.200

9.  Current Trends in GPCR Allostery.

Authors:  Khuraijam Dhanachandra Singh; Sadashiva S Karnik
Journal:  J Membr Biol       Date:  2021-01-20       Impact factor: 1.843

10.  A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.

Authors:  Man Li; Zhen Liang; Xun Sun; Tao Gong; Zhirong Zhang
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.